Current possibilities in the treatment of posttraumatic cognitive disturbances

Odinak M.M.; Vorobyev S.V.; Lobzin V.Iu.; Emelin A.Iu.; Kudiasheva A.V.

doi:https://doi.org/

Odinak M.M.

Kafedra nervnykh bolezneĭ Voenno-meditsinskoĭ akademii im. S.M. Kirova, Sankt-Peterburg

Vorobyev S.V.

Rostov State Medical University, Rostov-on-Don, Russia

Lobzin V.Iu.

Kafedra nervnykh bolezneĭ i kafedra psikhiatrii Voenno-meditsinskoĭ akademii, Sankt-Peterburg

Emelin A.Iu.

kafedra nervnykh bolezneĭ Voenno-meditsinskoĭ akademii, Sankt-Peterburg

Kudiasheva A.V.

Current possibilities in the treatment of posttraumatic cognitive disturbances

Authors:

Odinak M.M., Vorobyev S.V., Lobzin V.Iu., Emelin A.Iu., Kudiasheva A.V.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2011;111(9): 73‑76

Read: 731 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Odinak MM, Vorobyev SV, Lobzin VIu, Emelin AIu, Kudiasheva AV. Current possibilities in the treatment of posttraumatic cognitive disturbances. S.S. Korsakov Journal of Neurology and Psychiatry. 2011;111(9):73‑76. (In Russ.)

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)

Использование инфографики авторами научных работ

References:

Avedisova A.S., Yastrebov D.V. Sravnitel'naya effektivnost' Noopepta i piratsetama pri terapii astenicheskikh rasstroistv i narushenii organicheskogo geneza. RMZh 2007; 15: 5: 1-5.
Andreeva G.O., Bazilevich S.N., Bisaga G.N. i dr. Chastnaya nevrologiya. M: OOO "Meditsinskoe informatsionnoe agentstvo" 2009; 576.
Arsen'eva K.E. Nootropnye preparaty v lechenii tserebrovaskulyarnykh zabolevanii. Rus med zhurn 2007; 15: 4: 1-4.
Bochkarev V.K., Teleshova E.S., Syunyakov S.A. i dr. Kliniko-elektroentsefalograficheskaya kharakteristika deistviya noopepta u bol'nykh s legkimi kognitivnymi rasstroistvami posttravmaticheskogo i sosudistogo geneza. Zhurn nevrol i psikhiat 2008; 108: 11: 47-54.
Gavrilova S.I., Kolykhalov I.V., Fedorova Ya.B. i dr. Opyt klinicheskogo primeneniya Noopepta v lechenii sindroma myagkogo kognitivnogo snizheniya. Sovremennaya terapiya psikhicheskikh rasstroistv 2008; 1: 27-32.
Damulin I.V. Vtorichnye dementsii (kognitivnye rasstroistva pri travmaticheskikh i opukholevykh porazheniyakh golovnogo mozga, pri infektsionnykh i autoimmunnykh zabolevaniyakh). M: MMA im. I.M. Sechenova 2009; 37.
Lesiovskaya E.E., Marchenko N.V., Pivovarova A.S. Sravnitel'naya kharakteristika lekarstvennykh sredstv, stimuliruyushchikh TsNS. Nootropnye preparaty. M: FARMindeks PRAKTIK 2003; 4: 20-53.
Lobzin V.Yu., Odinak M.M., Emelin A.Yu. Sosudistaya dementsiya. Vestn Ros voen-med akad 2004; 11: 1: 120-124.
Neznamov G.G., Teleshova E.S. Rezul'taty sravnitel'nogo izucheniya noopepta i piratsetama pri lechenii bol'nykh s legkimi kognitivnymi narusheniyami pri organicheskikh zabolevaniyakh golovnogo mozga sosudistogo i travmaticheskogo geneza. Zhurn nevrol i psikhiat 2008; 108: 3: 33-42.
Neznamov G.G., Teleshova E.S., Syunyakov S.A. i dr. Novyi peptidnyi preparat "Noopept" u bol'nykh s psikhoorganicheskimi rasstroistvami. Spravochnik poliklinicheskogo vracha 2007; 2: 86-88.
Odinak M.M. Nevrologicheskie oslozhneniya cherepno-mozgovoi travmy: Avtoref. dis. … d-ra med. nauk. St-Peterburg 1995; 44.
Odinak M.M., Emelin A.Yu., Lobzin V.Yu. Narushenie kognitivnykh funktsii pri tserebrovaskulyarnoi patologii. St-Peterburg: VMedA 2006; 158.
Ostrovskaya R.U., Gudasheva T.A., Voronina T.A., Seredenin S.B. Original'nyi nootropnyi i neiroprotektivnyi dipeptid noopept (GVS-111). Eksper i klin farmakol 2002; 65: 5: 66-72.
Ostrovskaya R.U., Gudasheva T.A., Tsaplina A.P. i dr. Noopept stimuliruet ekspressiyu NGF i BDNF v gippokampe krysy. Byull eksper biol i med 2008; 146: 9: 310-313.
Potapov A.A., Roshal' L.M., Likhterman L.B., Kravchuk A.D. Cherepno-mozgovaya travma: problemy i perspektivy. Voprosy neirokhirurgii 2009; 2: 3-8.
Yakhno N.N., Damulin I.V., Antonenko L.M. Noopept v lechenii distsirkulyatornoi entsefalopatii s umerennymi kognitivnymi narusheniyami. Lechashchii vrach 2009; 5: 2-6.
Andelic N., Sigurdardottir S., Brunborg C., Roe C. Incidence of Hospital-Treated Traumatic Brain Injury in the Oslo Population. Neuroepidemiology 2008; 30: 2: 120-128.
van Baalen B. Clinimetrics and functional outcome one year after traumatic brain injury. Netherlands, Oisterwijk: Proefschriftmaken.nl 2008; 177.
Maas A.I.R., Stocchetti N., Bullock R. Moderate and severe traumatic brain injury in adults. Lancet Neurol 2008; 7: 8: 728-741.
Norris C.M., Scheff S.W. Recovery of afferent function and synaptic strength in hippocampal CA1 following traumatic brain injury. J Neurotrauma 2009; 26: 12: 2269-2278.
Orth M., Schapira A.H. Mitochondria and degenerative disorders. Am J Med Genet 2001; 106: 1: 27-36.
Parsons C., Danysz W., Hesselink M. et al. Modulation of NMDA receptors by glycine-introduction to some basic aspects and recent developments. Amino Acids 1998; 14: 1-3: 207-216.